| Cell physiology source book: essentials of membrane biophysics N Sperelakis Elsevier, 2012 | 157 | 2012 |
| Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration I Bala, V Bhardwaj, S Hariharan, SV Kharade, N Roy, MNV Ravi Kumar Journal of drug targeting 14 (1), 27-34, 2006 | 135 | 2006 |
| Muscle 2-Volume Set: Fundamental Biology and Mechanisms of Disease J Hill, E Olson Academic Press, 2012 | 110 | 2012 |
| Mrg19 depletion increases S. cerevisiae lifespan by augmenting ROS defence SV Kharade, N Mittal, SP Das, P Sinha, N Roy FEBS letters 579 (30), 6809-6813, 2005 | 62 | 2005 |
| The β3 Subunit Contributes to Vascular Calcium Channel Upregulation and Hypertension in Angiotensin II–Infused C57BL/6 Mice SV Kharade, SK Sonkusare, AK Srivastava, KM Thakali, TW Fletcher, ... Hypertension 61 (1), 137-142, 2013 | 61 | 2013 |
| Discovery, characterization, and effects on renal fluid and electrolyte excretion of the Kir4. 1 potassium channel pore blocker, VU0134992 SV Kharade, H Kurata, AM Bender, AL Blobaum, EE Figueroa, A Duran, ... Molecular pharmacology 94 (2), 926-937, 2018 | 49 | 2018 |
| Intracellular Ca2+ Silences L-Type Ca2+ Channels in Mesenteric Veins: Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers KM Thakali, SV Kharade, SK Sonkusare, SW Rhee, JR Stimers, NJ Rusch Circulation research 106 (4), 739-747, 2010 | 37 | 2010 |
| The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics. C Kharade, Sujay V., Nichols, J Denton Future Med Chem., 2016 | 30 | 2016 |
| Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics DR Swale, SV Kharade, JS Denton Current opinion in pharmacology 15, 7-15, 2014 | 30 | 2014 |
| Spectrophotometric estimation of ambroxol hydrochloride in tablets BS Kuchekar, GS Shinde, IT Naikawadi, KJ Todkar, SV Kharade Indian journal of pharmaceutical sciences 65 (2), 193-195, 2003 | 30 | 2003 |
| Discovery and characterization of VU0529331, a synthetic small-molecule activator of homomeric G protein-gated, inwardly rectifying, potassium (GIRK) channels KA Kozek, Y Du, S Sharma, FJ Prael III, BD Spitznagel, SV Kharade, ... ACS chemical neuroscience 10 (1), 358-370, 2018 | 27 | 2018 |
| ML418: The first selective, sub-micromolar pore blocker of Kir7. 1 potassium channels DR Swale, H Kurata, SV Kharade, J Sheehan, R Raphemot, KR Voigtritter, ... ACS chemical neuroscience 7 (7), 1013-1023, 2016 | 26 | 2016 |
| The LRRC8 volume‐regulated anion channel inhibitor, DCPIB, inhibits mitochondrial respiration independently of the channel A Afzal, EE Figueroa, SV Kharade, K Bittman, BK Matlock, DK Flaherty, ... Physiological reports 7 (23), e14303, 2019 | 20 | 2019 |
| Pore polarity and charge determine differential block of Kir1. 1 and Kir7. 1 potassium channels by small-molecule inhibitor VU590 SV Kharade, JH Sheehan, EE Figueroa, J Meiler, JS Denton Molecular pharmacology 92 (3), 338-346, 2017 | 18 | 2017 |
| ROMK inhibitor actions in the nephron probed with diuretics SV Kharade, D Flores, CW Lindsley, LM Satlin, JS Denton American Journal of Physiology-Renal Physiology 310 (8), F732-F737, 2016 | 17 | 2016 |
| Structure-activity relationships, pharmacokinetics, and pharmacodynamics of the Kir6. 2/SUR1-specific channel opener VU0071063 SV Kharade, JV Sanchez-Andres, MG Fulton, EL Shelton, AL Blobaum, ... Journal of Pharmacology and Experimental Therapeutics 370 (3), 350-359, 2019 | 16 | 2019 |
| A selective inhibitor of the sperm-specific potassium channel SLO3 impairs human sperm function M Lyon, P Li, JJ Ferreira, RM Lazarenko, SV Kharade, M Kramer, ... Proceedings of the National Academy of Sciences 120 (4), e2212338120, 2023 | 14 | 2023 |
| Tocotrienol-rich fraction from rice bran demonstrates potent radiation protection activity KJ Krager, EN Pineda, SV Kharade, M Kordsmeier, L Howard, PJ Breen, ... Evidence-Based Complementary and Alternative Medicine 2015, 2015 | 11 | 2015 |
| Discovery and in vitro optimization of 3-sulfamoylbenzamides as ROMK inhibitors MF Sammons, SV Kharade, KJ Filipski, M Boehm, AC Smith, A Shavnya, ... ACS Medicinal Chemistry Letters 9 (2), 125-130, 2018 | 9 | 2018 |
| VU6036720: The first potent and selective in vitro inhibitor of heteromeric Kir4. 1/5.1 inward rectifier potassium channels SJ McClenahan, CN Kent, SV Kharade, E Isaeva, JC Williams, C Han, ... Molecular Pharmacology 101 (5), 357-370, 2022 | 8 | 2022 |
